Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• Are health-related, lifestyle, work-related, and socio-demographic factors associated with work productivity among menopausal women? A systematic review1 passage
• Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women1 passage
• Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials1 passage
• Drug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement1 passage
• EMAS position statement: Thyroid disease and menopause1 passage
• Effect of Lactobacillus-based probiotics on genitourinary syndrome of menopause in post-menopausal women: A systematic review1 passage
• Effect of fezolinetant on patient-reported quality-of-life outcomes: Data from a phase 3b study (DAYLIGHT) of the treatment of moderate to severe vasomotor symptoms associated with menopause in women considered unsuitable for hormone therapy1 passage
• Effect of oral phytoestrogens on endometrial thickness and breast density of perimenopausal and postmenopausal women: A systematic review and meta-analysis1 passage
• Effect of physical activity on sleep in women experiencing vasomotor symptoms during menopause: a systematic review and meta-analysis1 passage
• Effect of testosterone replacement therapy on fracture risk in hypogonadal men: A systematic review and meta-analysis of randomized controlled trials1 passage
• Effectiveness of a digital cognitive behavioral therapy application for vasomotor symptoms in menopausal women: An open-label pilot randomized controlled trial1 passage
• Effectiveness of non-pharmacological interventions for insomnia related to natural menopause: A meta-analysis of randomized controlled trials1 passage
• Effects of a digital voice assistant-delivered osteoporosis self-management program on diet in postmenopausal women with osteoporosis: A secondary analysis of a 12-month feasibility randomised controlled trial1 passage
• Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis1 passage
• Eligibility criteria for Menopausal Hormone Therapy (MHT): a position statement from a consortium of scientific societies for the use of MHT in women with medical conditions. MHT Eligibility Criteria Group1 passage
• Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases1 passage
• Handgrip strength in patients with subclinical hypothyroidism or subclinical hyperthyroidism compared with that in euthyroid individuals: A systematic review and meta-analysis1 passage
• Italian Association of Sleep Medicine (AIMS) position statement and guideline on the treatment of menopausal sleep disorders1 passage
• Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia1 passage
• Menopause symptom management in women with dyslipidemias: An EMAS clinical guide1 passage
• Microablative and non-ablative laser and radiofrequency treatment of genitourinary syndrome of menopause: A randomised controlled trial with four different energies1 passage
• Neurokinin pathway botanical antagonist for menopausal vasomotor symptoms: A randomized, double-blind, placebo-controlled study1 passage
• PERCEIVE: A retrospective, qualitative interview-based study of the impact of vasomotor symptoms associated with menopause on the lives of individuals who are not suitable candidates for hormone therapy1 passage
• Resistance training for hot flushes in postmenopausal women: Randomized controlled trial protocol1 passage
• Revised global consensus statement on menopausal hormone therapy1 passage
• Role of dietary fibre in older adults with asymptomatic (AS) or symptomatic uncomplicated diverticular disease (SUDD): Systematic review and meta-analysis1 passage
• Study protocol of a multicentre randomised controlled trial of self-help cognitive behaviour therapy for working women with menopausal symptoms (MENOS@Work)1 passage
• Systematic review and meta-analysis of the effects of progestins on depression in post-menopausal women: An evaluation of randomized clinical studies that used validated questionnaires1 passage
• Systematic review and narrative synthesis of cognition in perimenopause: The role of risk factors and menopausal symptoms1 passage
• Systematic review on the relationship between menopausal hormone replacement therapy, sarcopenia, and sarcopenia-related parameters1 passage
• The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis1 passage
• The effect of hormone therapy on vaginal microbiota in women with genitourinary syndrome of menopause: A double-blind, randomized, placebo-controlled trial1 passage
• The feasibility and effects of a telehealth-delivered physical therapy program for postmenopausal women with urinary incontinence: A pilot mixed-methods study1 passage